✍ Scribed by M. Fátima Cabral; Rita Delgado
No coin nor oath required. For personal study only.
Four macrocyclic ligands have been synthesized: 1‐oxa‐4,7,10,13‐tetraazacyclopentadecane (1), 1,4‐dioxa‐7,10,13‐triazacyclopentadecane (2), 1,4‐dioxa‐7,11,14‐triazacyclohexadecane (3), 1,4‐dioxa‐7,11,15‐triazacycloheptadecane (4), one of them 3, for the first time. The protonation constants of the ligands and the stability constants of the complexes formed by the four ligands with some divalent first‐series transition‐metal ions, Cd^2+^ and Pb^2+^, were determined by potentiometric methods, in aqueous solution, at 25° and I = 0.10M (KNO~3~). The sequence of protonation of ligand 1 was studied by ^1^H‐NMR spectroscopy. The Irving‐Williams' order of stability is obeyed for the complexes of all the ligands, and the metal complexes of 1 present the higher values of stability. A drop in the stability of all the metal complexes studied is observed when the metal complexes of 1 are compared with the corresponding complexes of 2. The effect of the increase of the ring size of the macrocycle can be observed for metal complexes of the series of ligands 2 4, where, in spite of the slight increase of the overall basicity of the ligands (20.28, 22.25, and 24.96 for 2, 3, and 4 respectively), small differences in stability are found for the corresponding complexes of 2 and 3, but a significant drop occurs for all the metal complexes formed with the 17‐membered ligand, specially for the larger metal ions like Mn^2+^ and Pb^2+^.
📜 SIMILAR VOLUMES
## Abstract Intensely coloured, extremely moisture sensitive complexes [VOCl~3~(L)] (L = pyridine, quinoline, Ph~3~PO, Ph~3~AsO, pyridine __N__‐oxide), [VOCl~3~(L)~2~] (L = pyridine, Me~3~PO, pyridine __N__‐oxide), [VOCl~3~(L–L)] [L–L = 2,2′‐bipyridyl, 1,10‐phenanthroline, Ph~2~P(O)CH~2~P(O)Ph~2~,
As a first step toward design of biomimetic functional molecules based on macrocycles containing metal ions as ring atoms, metal complexation by a noncyclic ligand containing distant chelating sites was undertaken. For this purpose, tetradentate ligand \(N, N^{\prime}\)-di[3-(2imidazolylazo)phenyl]-